TuesdayNov 28, 2023 4:20 am

420 with CNW — Rescheduling Cannabis Could Lead to Broader Acceptance by the Mainstream Medical Industry

Moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) could have significant implications for medical cannabis recommendations by doctors and potential insurance coverage for marijuana treatments. Currently, doctors refrain from prescribing state-regulated medical cannabis due to the risk of losing their licenses given that it lacks approval from the U.S. Food and Drug Administration (FDA). Even if the Drug Enforcement Administration (DEA) reschedules cannabis, the prohibition on doctors prescribing state-regulated medical marijuana (MMJ) products would persist. Nevertheless, doctors could continue to recommend non-FDA-approved cannabis products to individuals seeking MMJ cards, allowing them to register as…

Continue Reading

MondayNov 27, 2023 4:20 pm

420 with CNW — Regulators in New York Reach Settlement Regarding Marijuana Business Licensing

Cannabis regulators in the state of New York have reached a settlement with veterans who had filed a suit over the licensing process in the state. The settlement’s completion will allow an injunction that was effected from August to be lifted. The temporary injunction, which was enacted by the state’s Supreme Court, has prevented hundreds of holders of conditional adult-use retail dispensary licenses from launching their businesses. Regulators in the state launched the recreational retail-dispensary program to afford those who were disproportionately affected by the drug war before marijuana became legal an opportunity to enter the legal marijuana industry. The…

Continue Reading

MondayNov 27, 2023 4:20 am

420 with CNW — NORML Deputy Director Calls Out Republican Politicians for Trying to Subvert Voters’ Wishes on Marijuana

Paul Armentano, who works as deputy director at NORML, a nonprofit aimed at advocating for the reform of marijuana laws, recently penned a post for The Hill in which he expressed concerns about a growing trend in which GOP lawmakers in different states have actively taken steps to subvert the wishes of voters with regard to marijuana legalization. Recently, Ohioans made a decisive choice in favor of Issue 2 — a citizen-driven ballot initiative marking a significant step toward legalizing the cultivation, possession and sale of recreational cannabis. The vote was in line with a broader national trend where, across…

Continue Reading

WednesdayNov 22, 2023 4:20 pm

420 with CNW — Study Suggests Cannabis Enables Users Quit Prescription Sleep Medications

A recent study into the sleep habits of marijuana users facing sleep difficulties shows that a majority of participants prefer cannabis over other sleep aids, citing improved outcomes the following morning and fewer side effects. The consumption of CBD, THC and myrcene-infused joints or vaping products emerged as particularly popular choices among participants. Contrasted with conventional sleep aids or abstaining from them altogether, respondents conveyed a heightened sense of refreshment, focus and improved functionality in the mornings after using cannabis. This was coupled with a decrease in nausea and headaches. However, users did acknowledge some adverse effects, such as waking…

Continue Reading

WednesdayNov 22, 2023 4:20 am

420 with CNW — Gallup Poll Finds Most Americans Disenchanted with Federal Drug Policy

A new survey has found that more than 50% of Americans believe the country has lost ground in the war on drugs. The poll, conducted by Gallup, also showed that 24% of respondents believed America had made progress. This is quite a difference from responses given on the same query in a 2019 survey, which stood at 30% for losing ground to 41% for making progress. This difference can be attributed to growing concern and awareness about the opioid epidemic, which has seen many individuals fall victim to drugs such as fentanyl. The shift may also reflect increased awareness on…

Continue Reading

TuesdayNov 21, 2023 4:20 pm

420 with CNW — Could Rescheduling Make Marijuana Interstate Commerce Possible?

There is optimism among some marijuana executives that the federal government’s potential reclassification of cannabis from Schedule 1 to Schedule 3 could open the door for interstate commerce in marijuana products. However, legal experts in the marijuana industry caution that this optimism is only partially warranted. Schedule 3, along with Schedules 4 and 5, currently allows interstate commerce only for drugs that have received approval from the FDA. This approval includes drugs such as testosterone, ketamine, anabolic steroids and certain formulations of THC, such as Syndros, Marinol and dronabinol. The crucial factor, according to Bianchi and Brandt attorney Justin Brandt,…

Continue Reading

TuesdayNov 21, 2023 4:20 am

420 with CNW — Congressional Researchers Say High Federal Taxes on Marijuana May Hamper Industry’s Economic Potential

The Congressional Research Service recently published a report that cautions legislators to consider the possible consequences of levying high taxes on cannabis products in the event that marijuana gets legalized federally. This comes as Congress considers several reform initiatives and the DEA concludes its review of marijuana scheduling and makes a decision on whether or not to reclassify cannabis as a Schedule 3 drug under the Controlled Substances Act, as recommended by the U.S. Health and Human Services Department. In a previous report, the nonpartisan research body argued that the DEA was likely to reschedule cannabis based on previous precedents.…

Continue Reading

MondayNov 20, 2023 4:20 pm

420 with CNW — Survey Shows Growing Investor Interest in Cannabis MSOs

A recent survey indicates a growing optimism among institutional investors towards U.S. marijuana multistate operators (MSOs). Conducted by Calgary-based ATB Capital Markets, the survey involved 23 institutional investors, primarily hedge funds. Frederico Gomes, the lead author of the report and a marijuana equity analyst, highlighted the increased bullish sentiment among investors, driven primarily by the potential rescheduling of marijuana by the federal government. The survey reveals that about 61% of respondents believe U.S. marijuana MSOs will outperform the S&P 500 in the next year. However, despite this positive sentiment, Gomes notes that the capital influx has not yet aligned with…

Continue Reading

MondayNov 20, 2023 4:20 am

420 with CNW — Prohibitionist States Register More Cannabis-Use Disorder Cases Than States with Legal Marijuana Markets

New research shows that the likelihood of a patient visiting an ER and getting a cannabis use disorder diagnosis is 50% lower in legal cannabis states in comparison to prohibitionist states. The research examined data obtained from emergency departments for the period between 2017–2020. Researchers focused on the states of Oregon and Colorado, which have legalized marijuana, and Rhode Island and Maryland, which still prohibit the use of marijuana. Specifically, the researchers assessed “treat & release” visiting rates, in which patients received cannabis-use disorder diagnoses that indicated problematic use of the substance. In total, the researchers had to analyze more…

Continue Reading

FridayNov 17, 2023 4:20 pm

420 with CNW — Ohio GOP Governor Asks Legislature to Modify Voter-Passed Cannabis Measure Before It Takes Effect

Last week, the governor of Ohio urged legislators to revise the state’s cannabis legalization law before adult possession and cultivation became legal in December. The measure in question, Issue 2, was approved by voters a few days prior.  Gov. Mike DeWine appealed to GOP leadership in the legislature to amend provisions that would limit public consumption, alleviate risk of impaired driving and restrict advertising. The governor has already scheduled a meeting with House Speaker Jason Stephens and Senate President Matt Huffman to discuss how to address what he terms as “holes” in this statutory measure.  In his statement, the governor…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000